Prenetics Global Ltd (PRE)
Prenetics Global Ltd reported revenue of $30.6M in fiscal 2024, up 40.8% from a year earlier. It posted a net loss of $46.3M. In fiscal 2024 capital spending exceeded operating cash flow by $29.9M. At December 31, 2024 it held $52.3M in cash. Its latest periodic report to the SEC is the annual report (foreign issuer, amended) (20-F/A) filed on September 4, 2026.
Key facts about Prenetics Global Ltd
- Net worth
- Prenetics Global Ltd has a market value (market cap) of $294.5M at the latest share price, and shareholders' equity of $170.4M on its balance sheet at December 31, 2024. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Revenue and profit
- In fiscal 2024 revenue was $30.6M (+40.8% year on year), with a net loss of $46.3M.
- Cash flow
- In fiscal 2024 operations used $28.9M of cash.
- Latest report
- The latest periodic report (annual report (foreign issuer, amended), 20-F/A) was filed with the SEC on September 4, 2026 and covers the period to December 31, 2025. Open on SEC EDGAR
What Prenetics Global Ltd does
Prenetics Global Ltd is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker PRE.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2024 | $30.6M | -$46.3M | -$3.71 | -$29.9M |
| 2023 | $21.7M | -$62.7M | -$5.58 | -$14.1M |
| 2022 | $13.2M | -$190.5M | -$37.57 | $9.6M |
| 2022 | $12.5M | -$174M | -$178.81 | $4.9M |
| 2020 | $65.2M | -$1.9M | -$2.25 | -$5.7M |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Where PRE ranks in Finance
Latest SEC filings
What Prenetics Global Ltd has filed recently, newest first. Each links to the original document on SEC EDGAR.
- November 5, 2026
- November 3, 2026
- November 2, 2026
- October 13, 2026
- September 22, 2026
- September 8, 2026
- September 4, 2026Annual report (foreign issuer, amended) 20-F/A · period to December 31, 2025
- August 26, 2026
- August 21, 2026
- August 20, 2026
Insider trades
What the people running Prenetics Global Ltd did with its shares, from the Form 4 filings they must send the SEC within two business days.
Insiders bought $999.7K worth of shares on the open market in the last 90 days and sold none.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| November 4, 2026 | Leogrande Hudson BlakeDirector | Exercised options | 2,000 | - |
| October 4, 2026 | Leogrande Hudson BlakeDirector | Exercised options | 2,000 | - |
| September 30, 2026 | Lo Hoi ChunChief Financial Officer | Exercised options | 7,635 | - |
| September 4, 2026 | Leogrande Hudson BlakeDirector | Exercised options | 2,000 | - |
| August 25, 2026 | Rosin Brian JCFO of IM8 (US) LLC | Bought | 5,100 | $116.3K |
| August 24, 2026 | Rosin Brian JCFO of IM8 (US) LLC | Bought | 18,000 | $381.4K |
| August 24, 2026 | Yeung Danny Sheng WuChief Executive Officer, Director | Bought | 6,000 | $125.4K |
| August 24, 2026 | Yeung Danny Sheng WuChief Executive Officer, Director | Bought | 11,181 | $239.3K |
Who owns PRE
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Genetel Bioventures Limited13G, passive with 1 related filers | 5.8% | November 14, 2024 |
Largest institutional holders
Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 25 managers reported a position.
| Holder | Shares | Change on quarter |
|---|---|---|
| Prospect Capital Advisors, LLC | 235,800 | new |
| Jane Street Group, LLC | 225,093 | +182,907 |
| Goldman Sachs Group Inc | 168,733 | -24,850 |
| Millennium Management LLC | 126,086 | -66,514 |
| Tenzing Global Management, LLC | 125,000 | -75,000 |
| Marshall Wace, Llp | 47,327 | -26,005 |
| Nomura Holdings Inc | 42,101 | -33,518 |
| Susquehanna International Group, Llp | 38,126 | +5,002 |
| UBS Group AG | 37,040 | +10,267 |
| XTX Topco Ltd | 30,485 | -2,932 |
| Stevens Capital Partners | 28,147 | 0 |
| Qube Research & Technologies Ltd | 23,810 | +4,680 |
| Morgan Stanley | 23,443 | +6,350 |
| Citadel Advisors LLC | 16,187 | new |
| Integrated Quantitative Investments LLC | 13,602 | 0 |
| EntryPoint Capital, LLC | 12,058 | new |
| Wells Fargo & Company | 10,000 | -74,806 |
| Operose Advisors LLC | 6,750 | new |
| State of Wyoming | 5,566 | +3,067 |
| Simplex Trading, LLC | 773 | +417 |
Insiders
6 insiders reported holding 823,465 shares in total, about $14.5M at the last price.
| Holder | Shares |
|---|---|
| Lo Hoi ChunChief Financial Officer | 573,648 |
| Yeung Danny Sheng WuChief Executive Officer, Director | 112,416 |
| Cheng Yin PanDirector | 59,05159,051 held indirectly |
| Vanderveen DavidDirector | 45,249 |
| Rosin Brian JCFO of IM8 (US) LLC | 23,100 |
| Leogrande Hudson BlakeDirector | 10,001 |
Questions about PRE
What does Prenetics Global Ltd do?
Prenetics Global Ltd is a company in the Finance sector, listed on NASDAQ as PRE. Its shares trade on NASDAQ under the ticker PRE.
What is Prenetics Global Ltd's net worth?
Prenetics Global Ltd has a market value (market cap) of $294.5M at the latest share price, and shareholders' equity of $170.4M on its balance sheet at December 31, 2024. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is Prenetics Global Ltd profitable?
No. In fiscal 2024 it reported a net loss of $46.3M on revenue of $30.6M.
How much revenue does Prenetics Global Ltd make?
In fiscal 2024 Prenetics Global Ltd reported revenue of $30.6M. That is 40.8% more than a year earlier.
When did Prenetics Global Ltd last report?
Its most recent periodic report is the annual report (foreign issuer, amended) (20-F/A) filed on September 4, 2026. It covers the period to December 31, 2025. Its newest filing of any kind is the foreign issuer update from November 5, 2026.
Similar companies
Compare PRE with
Follow PRE
Get an email when Prenetics Global Ltd files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values Prenetics Global Ltd tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.